In line with this consideration, however, LAP blocking antibody has been proven to reduce tumor growth in animal models of melanoma, colorectal carcinoma, and glioblastoma by decreasing the number of GARP+LAP+ Tregs [91]. Here, TGFB1 is linked to melanoma.